NanoDiagnostics Incorporated (NanoDX) has continued to have challenges with releasing their
SARS-CoV-2 detection system. This has slowed progress towards volume production.
Notwithstanding, Sensera has been asked to start the ramp of sensors in Q1 of FY22. ....
More waiting....
I don't think the market will be particularly overjoyed.
- Forums
- ASX - By Stock
- Ann: Quarterly Update and Appendix 4C
NanoDiagnostics Incorporated (NanoDX) has continued to have...
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)